Company overview
Basic information
Company name
Polibrolis, MB
Company code
307194265
VAT code
LT100018529819
Registered address
Vilnius, Rugių g. 1-202, LT-08418
Registration date
2025-06-09
Company age: 1 y. 4 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
https://polibrolis.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Repair and maintenance of motor vehicles
Ownership form
Private without foreign capital
MB Polibrolis
Company code: 307194265
Address: Vilnius, Rugių g. 1-202, LT-08418
VAT code: LT100018529819
Description
This description was generated by artificial intelligence.
Polibrolis, MB (company code 307194265) is an operational private small partnership registered on 2025-06-09. It is classified as a micro company in the national private non-financial companies sector and is governed by a CEO only. The company is privately owned, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Its registered address is Vilnius, Rugiu g. 1-202, LT-08418, in Vilniaus m. municipality, Vilniaus county. The company’s main activity is NACE code T.95.31.00, Repair and maintenance of motor vehicles. In 2025, covering a 205-day period, it generated revenue of EUR 25.2K and recorded a net loss of EUR 27.5K, resulting in a profit margin of -109.0%. At year-end 2025, total assets were EUR 26.1K, including EUR 22.9K in long-term assets and EUR 3.3K in short-term assets, while liabilities stood at EUR 53.6K. The average workforce in 2025 was 4 employees, with an average monthly wage of EUR 234.96. The staff dataset is marked as latest for so far in 2026, although the provided average staff figures are for 2025.
Download a detailed company report
Make confident decisions with all the information about Polibrolis, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.